[PDF] Top 20 La pertinencia curricular y social en las instituciones de educación superior
Has 10000 "La pertinencia curricular y social en las instituciones de educación superior" found on our website. Below are the top 20 most common "La pertinencia curricular y social en las instituciones de educación superior".
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
... for COPD (May 2016), “activity scales such as TDI that require patients to recall prior symptoms are problematic, because patients’ memories may fade over time, particularly in studies lasting several ...of ... See full document
30
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
... with COPD is represented by severe acute exacerbations of the disease, that is, those requiring patients’ hospitalization, constituting a substantial social and health care burden in terms of morbidity and medical ... See full document
25
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
... An extrafine formulation of the long-acting muscarinic antagonist glycopyrronium bromide (GB) is in development for chronic obstructive pulmonary disease (COPD), in combina- tion with ... See full document
27
Pharmacokinetics of glycopyrronium/formoterol <br />fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
... of glycopyrronium (GP)/formoterol fumarate dihydrate (FF) ...of glycopyrronium and formoterol following administration of GFF MDI ... See full document
34
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
... This study was funded by Almirall S.A., Barcelona, Spain, and Forest Laboratories LLC, a subsidiary of Actavis, New York, NY, USA. The sponsors were responsible for conception and design of the study and ... See full document
12
Anhydrous beclomethasone dipropionate
... crystal X-ray diffractometry using direct methods. Beclo- methasone dipropionate, BDP, is an important pharmaceutical steroid for the treatment of asthma. It is formulated for inhalation delivery either as a ... See full document
105
A review of nebulized drug delivery in COPD
... in combination with a short-acting β -agonist (eg, albuterol) is not recommended in patients receiving concomitant therapy with an LAMA because of concern regarding possible additive anticholin- ergic side ... See full document
5
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
... Thus, while the inclusion of potential asthma patients may have biased results in favor of BFC, it is unlikely to account for the total magnitude of effect observed in this study, con- sidering the ability of tiotropium ... See full document
6
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
... Abstract: COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to ...LAMA/LABA fixed-dose combination (FDC) thera- pies, which provide ... See full document
6
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
... the patient inhales deeply and slowly through the mouth after device actuation to draw medication into the lungs. Proper hand-breath coordination of device actuation and inhalation is necessary to ensure that a ... See full document
9
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD
... Patients could be discontinued from the study early at the discretion of the investigator if (on two consecutive assessments ~ 15 minutes apart) they had a corrected QT interval using Fridericia’s correction factor .500 ... See full document
16
<p>Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap</p>
... triple therapy as a more aggressive therapy for disease associated with more symptoms and greater physician- perceived risk of ...22 Triple therapy with dis- tinct and complementary ... See full document
30
Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
... Patients and methods: We adopted a patient-level simulation model, which included a cohort of COPD patients aged $40 years. The intervention used in the study was the treatment using IND/GLY, and comparators were ... See full document
9
An ethanol solvate of Beclomethasone dipropionate
... drug. Beclomethasone dipro- pionate (BDP), a widely used corticosteroid for the treatment of chronic asthma, is currently formulated in metered dose inhalers ... See full document
113
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD
... MDI combination, or sponsor‑provided albuterol MDI, at the Investigator’s ...maintenance therapy were allowed to continue the ICS if they had been on a stable dose for 4 weeks or ...a fixed‑dose ... See full document
5
Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD
... The majority of treatment-emergent AEs (TEAEs) were considered mild or moderate, with only one patient who experienced a severe TEAE of worsening COPD following treatment with placebo MDI. Only two TEAEs ... See full document
16
Changes in ventilation–perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling
... A total of 42 patients with COPD participating in a mul- ticenter trial (NCT01684384) were included in this study. COPD was defined by the GOLD criteria. Patients had documented histories of ... See full document
15
<p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>
... severe COPD exacerbations vs. GFF MDI in Japanese patients with COPD despite the fact that these patients did not meet criteria for asthma-COPD ...that triple therapy with BGF MDI is ef ... See full document
6
A COMPARATIVE STUDY ON THE COMBINATION USE OF INDACATEROL WITH GLYCOPYRRONIUM AND FORMOTEROL WITH TIOTROPIUM IN COPD PATIENTS IN A TERTIARY CARE HOSPITAL
... respective study. The effectiveness of therapeutic strategy used in the patients was estimated by taking severity,frequency,symptom score,activity score,impact score and duration was taken into consideration. ... See full document
568
Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
... LABA/LAMA combination that could be delivered along with a corticosteroid, and here the evidence of safety and efficacy of aclidinium/formoterol combination raises a potential option to be ... See full document
13
Related subjects